Iris Romero to Xenograft Model Antitumor Assays
This is a "connection" page, showing publications Iris Romero has written about Xenograft Model Antitumor Assays.
Connection Strength
0.173
-
SPHK1 Is a Novel Target of Metformin in Ovarian Cancer. Mol Cancer Res. 2019 04; 17(4):870-881.
Score: 0.151
-
Foretinib (GSK1363089), an orally available multikinase inhibitor of c-Met and VEGFR-2, blocks proliferation, induces anoikis, and impairs ovarian cancer metastasis. Clin Cancer Res. 2011 Jun 15; 17(12):4042-51.
Score: 0.022